Oura and Counsel Health Expand Partnership Through CMS ACCESS Model

The intersection of consumer wearable technology and federally backed healthcare delivery is undergoing a significant transformation. Oura, the prominent health technology company renowned for its flagship Oura Ring smart ring, has announced a major expansion of its strategic partnership with Counsel, an artificial intelligence-native primary care provider. This collaboration is set to deploy under the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. The joint initiative represents a concerted effort to study and validate how continuous, real-world biometric tracking can be seamlessly integrated with physician-led clinical care to support aging populations managing persistent health conditions at scale.

Beginning in early 2027, Counsel will roll out specialized, AI-native chronic disease management services targeted at four major conditions: hypertension, obesity, hyperlipidemia, and prediabetes. Crucially, these comprehensive services will be provided at zero out-of-pocket cost to eligible Medicare beneficiaries residing across nearly all United States jurisdictions. By coupling continuous health monitoring with modern, accessible clinical oversight, the initiative aims to bridge the persistent gap between daily self-care and professional medical intervention, particularly for older adults who stand to benefit most from proactive chronic disease management.

Background Context and the Evolution of the Partnership

The announcement marks the next evolutionary phase in a collaborative relationship that formally commenced in May. The initial partnership was designed to streamline the journey for Oura members, allowing them to transition effortlessly from passive health insights generated by their smart rings to direct, actionable engagement with qualified clinicians. Since its inception, that initial integration has yielded strong user engagement and positive qualitative metrics. Members who utilized the platform to consult with physicians reported high satisfaction, rating their overall care experience an impressive 4.6 out of 5. This feedback underscored both the operational efficiency and the clinical value of bridging consumer wearables with on-demand telemedicine.

Building upon this early momentum, the integration into the CMS ACCESS Model elevates the collaboration from a commercial wellness feature to a federally recognized care delivery study. The ACCESS program, developed by the CMS Innovation Center, provides healthcare innovators and technology companies with a controlled framework to test and evaluate scalable care models. Through this federal pathway, Oura and Counsel will collect robust data on how continuous health telemetry influences patient outcomes, healthcare utilization, and the efficiency of chronic disease management for Medicare populations.

Addressing Chronic Conditions Among Aging Populations

The demographic profile of Oura’s user base provides a compelling rationale for this targeted healthcare intervention. Individuals aged 65 and older represent one of the company’s most consistently engaged cohorts, demonstrating exceptionally high daily interaction rates with the Oura mobile application. Furthermore, internal demographic data indicates that approximately 20 percent of Oura members within this senior demographic present with a Body Mass Index (BMI) of 30 or higher, placing them at an elevated risk for obesity-related comorbidities.

These metrics align precisely with the clinical focus of the ACCESS Model. Hypertension, obesity, hyperlipidemia, and prediabetes are among the most pervasive and costly drivers of morbidity, mortality, and healthcare expenditure in the United States, particularly within the Medicare population. By focusing on these specific cardio-kidney-metabolic conditions, the partnership targets the root causes of systemic health decline. Continuous monitoring of physiological markers—such as resting heart rate, heart rate variability, body temperature trends, and sleep architecture—provides clinicians with an unprecedented, round-the-clock window into a patient’s physiological baseline, allowing for early detection of deviations that precede acute clinical events.

How the Integrated Care Model Operates

The operational framework of the expanded partnership is designed to blend advanced computational intelligence with human clinical expertise. Counsel’s healthcare delivery model relies on proprietary medical artificial intelligence designed to analyze continuous incoming health streams and provide personalized guidance. However, this AI layer operates in tandem with on-demand access to board-certified physicians, ensuring that patients receive human oversight and empathetic medical decision-making.

For Medicare beneficiaries who also utilize an Oura Ring and explicitly consent to data sharing, the integration becomes deeply personalized. Biometric health insights captured continuously by the ring and processed within the Oura App are made accessible to Counsel’s clinical teams. This constant stream of objective health data removes the limitations of traditional, episodic doctor visits, where physicians must rely on retrospective patient recall or single-point-in-time measurements taken during office checkups. Armed with continuous data, physicians can tailor treatment plans, monitor therapeutic efficacy in real time, and intervene before minor physiological stressors escalate into severe health complications.

Official Statements and Industry Perspectives

Leadership from both organizations have emphasized the transformative potential of combining consumer health hardware with structured, federally supported clinical pathways.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," stated Dr. Ricky Bloomfield, Chief Medical Officer at Oura. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

The sentiment is shared by clinical and administrative leaders at Counsel, who view the partnership as a validation of their AI-native primary care infrastructure. By leveraging the CMS ACCESS Model, Counsel can scale its operational capacity while proving that technology-enabled, preventative care models can deliver high-quality outcomes for populations historically underserved by traditional, fragmented healthcare systems.

Enrollment Pathways and Timeline Leading to 2027

As the initiative prepares for its official rollout in early 2027, the operational mechanics between the two companies are being systematically established. Oura will serve as an informational bridge, utilizing the Oura App to raise awareness about the ACCESS program and introduce interested members to Counsel’s offerings.

However, regulatory compliance and clinical governance remain strictly separated. Counsel will independently verify the clinical eligibility of prospective participants, handle all administrative enrollment procedures, and retain full oversight of the subsequent medical care provided. Detailed guidelines and step-by-step instructions regarding how eligible Oura members can apply and enroll through the Oura mobile interface will be disseminated as the 2027 launch date approaches.

Implications for the Future of Digital Health and Medicare

The integration of continuous wearable telemetry into a CMS Innovation Center model signals a broader, paradigm-shifting acceptance of consumer technology within formal healthcare reimbursement and delivery frameworks. For decades, the digital health sector operated largely in parallel to traditional medicine, with consumer wellness devices categorized separately from clinical-grade medical equipment.

Initiatives like the Oura and Counsel ACCESS partnership help dissolve these artificial boundaries. By demonstrating that continuous biometric monitoring can be rigorously studied, safely scaled, and effectively coupled with physician-led interventions for Medicare beneficiaries, the collaboration offers a blueprint for the future of chronic disease management. If successful, the model could pave the way for broader policy changes, potentially expanding insurance coverage and reimbursement pathways for continuous health monitoring tools across wider segments of the American healthcare landscape.